This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slid 2.54% to $135.86 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.43% to 11,552.36 and Dow Jones Industrial Average falling 0.56% to 30,961.82. Moderna Inc. closed $322.64 short of its 52-week high ($458.50), which the company achieved on September 23rd.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) rose 2.12% to $142.51, Amgen Inc. (AMGN) fell 0.20% to $227.66, and AstraZeneca PLC ADR (AZN.LN) fell 0.99% to $58.14. Trading volume (4.2 M) remained 466,607 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2022.
(END) Dow Jones Newswires
September 15, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.